Effects of MDMA and intranasal oxytocin on social and emotional processing

Kirkpatrick, Matthew G, Lee, Royce, Wardle, Margaret C, Jacob, Suma, de Wit, Harriet·2014·Neuropsychopharmacology
DOI 10.1038/npp.2014.12

Cited by (142)

Items 101–142 of 142

  1. Independent elevation of peripheral oxytocin concentrations and reduction in cognitive empathy during 4‐fluoroamphetamine intoxication
    Patrick C. Dolder, Elizabeth B. de Sousa Fernandes Perna, Natasha Leigh Mason, Nadia R. P. W. Hutten, Stefan W. Toennes, Eef Lien Theunissen, Johannes Gerardus Ramaekers, Kim P. C. Kuypers · 2018 · Human Psychopharmacology Clinical and Experimental
  2. Potential for limited reinforcing and abuse-related subjective effects of intranasal oxytocin
    Sean B. Dolan, Meredith S. Berry, Patrick S. Johnson, Matthew W. Johnson · 2019 · Journal of Psychopharmacology
  3. Effects of four-week intranasal oxytocin administration on large-scale brain networks in older adults
    Peiwei Liu, Tian Lin, Håkan Fischer, David Feifel, Natalie C. Ebner · 2024 · Neuropharmacology
  4. Examining the potential of psilocybin and 5-MeO-DMT as therapeutics for traumatic brain injury
    Zoe Plummer, Josh Allen, Justin Brand, Leah M. Mayo, Sandy R. Shultz, Brian R. Christie · 2025 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
  5. Psychedelic Drugs in Mental Disorders: Current Clinical Scope and Deep Learning‐Based Advanced Perspectives
    Sung‐Hyun Kim, Sumin Yang, Jeehye Jung, Jeonghyeon Choi, Mingon Kang, Jae‐Yeol Joo · 2025 · Advanced Science
  6. Phonological Markers of Oxytocin and MDMA Ingestion
    Carla Agurto, Raquel Norel, Rachel Ostrand, Gillinder Bedi, Harriet de Wit, Matthew J. Baggott, Matthew G. Kirkpatrick, Margaret C. Wardle, Guillermo Cecchi · 2017 · Interspeech (USB)
  7. History, pharmacology and therapeutic mechanisms of 3,4‐methylenedioxymethamphetamine (MDMA)
    Austen B. Casey, Boris Dov Heifets · 2025 · British Journal of Pharmacology
  8. Novel behavioral tasks for the measurement of social motivation in mice: a comparison across strains
    Caitlyn Wells, Kendall P. Huddleston, Steven Brown, Fatima Razzaq, Donald Chick, Tiffany D. Rogers · 2026 · Frontiers in Behavioral Neuroscience
  9. From antidepressants and psychotherapy to oxytocin, vagus nerve stimulation, ketamine and psychedelics: how established and novel treatments can improve social functioning in major depression
    Aleksandra Kupferberg, Gregor Hasler · 2024 · Frontiers in Psychiatry
  10. Exploring the impact of MDMA and oxytocin ligands on anxiety and social responses: A comprehensive behavioural and molecular study in the zebrafish model
    Monika Maciąg, Olga Doszyn, Artur Wnorowski, Justyna Zmorzyńska, Barbara Budzyńska · 2025 · Journal of Psychopharmacology
  11. Mystical Love: The Universal Solvent
    Charles D. Laughlin, Melanie Takahashi · 2020 · Anthropology of Consciousness
  12. Subdiaphragmatic vagotomy reduces hypothalamic oxytocin expression and blood levels after oral MDMA administration in male rats
    Yong Gang Yue, Xiayun Wan, Guilin Liu, Tingting Zhu, Dan Xu, Mingming Zhao, Yi Cai, Rumi Murayama, Hirofumi Hashimoto, Naohiko Anzai et al. · 2025 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
  13. MDMA – hopes and fears associated with therapeutic use in mental disorders
    Kamil Kozera, Lena Cichoń, Krzysztof Maria Wilczyński, Małgorzata Honorata Janas-Kozik · 2020 · Pharmacotherapy in Psychiatry and Neurology
  14. The 3,4‐methylenedioxymethamphetamine enhances early visual processing for salient socio‐emotional stimuli
    Connor J. Haggarty, Anya K. Bershad, Mahesh K. Kumar, Royce Lee, Harriet de Wit · 2024 · European Journal of Neuroscience
  15. Social Homeostasis and Psychoactive Drugs: What Can We Learn From Opioid and Amphetamine Drug Challenge Studies in Humans?
    Anya K. Bershad, Harriet de Wit · 2024 · Biological Psychiatry
  16. Understanding the Psychological Effects of Psilocybin and 3,4-Methylenedioxymethamphetamine in a Non-Clinical Population
    Paul Bernard Fitzgerald, Samantha Lee Webb, Nigel Christopher Denning, Tra-ill Dowie, Monica Margaret Schweickle, Anish Modak, Grace Chan, Jackie Knight, Molly Waldron, Kirsten Gainsford et al. · 2025 · medRxiv
  17. Case Report: Amplified psychoanalysis? Psychoanalysis, OCD and MDMA in a clinical case study
    Filippo Dellanoce · 2026 · Frontiers in Psychology
  18. LSD acutely impairs fear recognition and enhances emotional empathy and sociality
    Patrick C. Dolder, Yasmin Schmid, Felix Müller, Stefan Borgwardt, Matthias E. Liechti · 2016 · European Neuropsychopharmacology
  19. MDMA for treatment of PTSD and neurorehabilitation in military populations
    Walter Dunn, Anya K. Bershad, David E. Krantz, Eric H. G. J. M. Vermetten · 2024 · Neurorehabilitation
  20. Pharmacological assistance for psychotherapy
    Jessica Lochtenberg, Ari P. Kirshenbaum, Matthew W. Johnson · 2021 · Emerging Trends in Drugs Addictions and Health
  21. Oxytocin and its links through scientific lineage
    Suma Jacob · 2024 · Comprehensive Psychoneuroendocrinology
  22. Clinical pharmacology
    Severin B. Vogt, Matthias E. Liechti · 2025 · International review of neurobiology
  23. The effect of MDMA administration on oxytocin concentration levels: systematic review and a multilevel meta-analysis in humans
    Anna Vaslavski, Anna Harwood-Gross, Salomon Israel, Leehe Peled‐Avron · 2025 · Neuroscience & Biobehavioral Reviews
  24. A meta-analytic analysis of the acute effects of MDMA on empathy and emotion recognition in humans
    Leehe Peled‐Avron, Jacob S. Aday, Madeline Marie Pantoni, Holly Hamilton, Joshua D. Woolley · 2025 · Scientific Reports
  25. Drogen- und Medikamentenabhängigkeit
    Tomislav Majić, Inge Mick, Thorsten Kienast, Andreas Heinz, Michael Soyka · 2016 · Springer eBooks
  26. Oxytocin and Body Weight Homeostasis — Wrong Hypothesis or Wrong Methodology?
    Hiroe Hu, Joseph George Verbalis · 2024 · NEJM Evidence
  27. Trauma Innovations: MDMA as a Treatment Intervention for PTSD
    Anthony Christian, Andrea E. Grey, Terra Sorg · 2015 · UST Research Online (University of St. Thomas - Minnesota)
  28. Using ‘hug drugs’ to understand affiliative behavior: the value of the social neurochemistry perspective.Commentary on:
    Ian D. Roberts, Baldwin M. Way · 2014 · Social Cognitive and Affective Neuroscience
  29. The Behavioral Effects of MDMA in Humans Under Controlled Laboratory Conditions
    Matthew G. Kirkpatrick, Casey R. Guillot, Carl L. Hart · 2016 · Elsevier eBooks
  30. Third-wave Cognitive Behavioral Therapy, Mindfulness, and Behavioral Activation
    Sonny Misa, Otd Muhlenhaupt, L Faota · 2019 · The Medicine Forum
  31. Effects of oxytocin on human aggression
    Alcorn, Lisa A. Joseph · 2014 · Digital Commons-TMC (Texas Medical Center)
  32. 怪僧ラスプーチンとロシアン・セックス (特別企画 セックスの壁)
    優 佐藤 · 2005 · 新潮45
  33. Drogen- und Medikamentenabhängigkeit
    Tomislav Majić, Thorsten Kienast, Andreas Heinz, Michael Soyka · 2017 · Springer eBooks
  34. Drugs and Consciousness
    Mustafa Hayder Kadhim · 2022 · Springer eBooks
  35. Advancements in drug intervention research for stress-related psychiatric disorders
    Yan GAO, Ning-long Xu, Zhong Chen, Minghu Han, Yingjie Zhu, Wei Wu, Min Zhao, Weimin Yang, Zhen Wang, Shumin Duan et al. · 2025 · Scientia Sinica Vitae
  36. Managing Co-occurring Substance use Problems in Eating Disorder Treatment
    Amy Baker Dennis, Brooke Lamphere, Tamara L. Pryor · 2025 · Psychiatric Clinics of North America
  37. MDMA in Psychiatry: From PTSD to emerging indications, safety, and future directions
    Mingming Zhao, Jianjun Yang, Kenji Hashimoto · 2025 · Psychedelics.
  38. Exploring MDMA assisted therapy in eating disorders: mechanisms, clinical evidence, and future directions
    Michael A Harkhoe, Tim M Offringa, Eric H. G. J. M. Vermetten · 2025 · Journal of Eating Disorders
  39. Measuring Altered States of Consciousness in Virtual Reality: A Systematic Analysis of Assessment Methods
    Maria Laura Mele, Hans M. Rutrecht · 2026 · Lecture notes in computer science
  40. The effects of acute and repeated adolescent MDMA exposure on behavior, cognition, and the monoamine neurotransmitter systems: A review of human and pre-clinical research
    Kristin A. Felsch, Jessica A. Siegel · 2026 · Behavioural Brain Research
  41. THE ROLE OF THE OXYTOCIN SYSTEM IN PATIENTS WITH HYPOTHALAMIC-PITUITARY DYSFUNCTION: A NARRATIVE REVIEW
    Maja Podolak, Aleksandra Serafin, Karolina Baran, Aleksandra Suchołbiak, Irmina Grygutis, Urszula Jarzęcka, Michał Karandys, Aleksandra Denkiewicz, Marta Hajduk · 2026 · International Journal of Innovative Technologies in Social Science
  42. Effects of acute inflammatory challenge on anhedonia and social reward processing: A randomized controlled trial of endotoxin
    Chloe C. Boyle, Flora Blandl, Naomi I. Eisenberger, Richard Olmstead, Joshua H. Cho, Dominique Piber, Michael R. Irwin · 2026 · Psychoneuroendocrinology